Dermata Therapeutics, Inc. (NASDAQ:DRMA) was the target of a large increase in short interest in July. As of July 15th, there was short interest totalling 52,600 shares, an increase of 141.3% from the June 30th total of 21,800 shares. Approximately 8.1% of the shares of the stock are short sold. Based on an average daily trading volume, of 1,080,000 shares, the short-interest ratio is presently 0.0 days.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.